Orian-Rousseau V - Search Results

1

CD44: More than a mere stem cell marker.

Morath I, Hartmann TN, Orian-Rousseau V. Morath I, et al. Int J Biochem Cell Biol. 2016 Dec;81(Pt A):166-173. doi: 10.1016/j.biocel.2016.09.009. Epub 2016 Sep 15. Int J Biochem Cell Biol. 2016. PMID: 27640754 Review.

2

Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin.

Orian-Rousseau V, Morrison H, Matzke A, Kastilan T, Pace G, Herrlich P, Ponta H. Orian-Rousseau V, et al. Mol Biol Cell. 2007 Jan;18(1):76-83. doi: 10.1091/mbc.e06-08-0674. Epub 2006 Oct 25. Mol Biol Cell. 2007. PMID: 17065554 Free PMC article.

3

Haploinsufficiency of c-Met in cd44-/- mice identifies a collaboration of CD44 and c-Met in vivo.

Matzke A, Sargsyan V, Holtmann B, Aramuni G, Asan E, Sendtner M, Pace G, Howells N, Zhang W, Ponta H, Orian-Rousseau V. Matzke A, et al. Mol Cell Biol. 2007 Dec;27(24):8797-806. doi: 10.1128/MCB.01355-07. Epub 2007 Oct 8. Mol Cell Biol. 2007. PMID: 17923692 Free PMC article.

4

A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis.

Tremmel M, Matzke A, Albrecht I, Laib AM, Olaku V, Ballmer-Hofer K, Christofori G, Héroult M, Augustin HG, Ponta H, Orian-Rousseau V. Tremmel M, et al. Blood. 2009 Dec 10;114(25):5236-44. doi: 10.1182/blood-2009-04-219204. Blood. 2009. PMID: 19773544 Free article.

5

CD44, a therapeutic target for metastasising tumours.

Orian-Rousseau V. Orian-Rousseau V. Eur J Cancer. 2010 May;46(7):1271-7. doi: 10.1016/j.ejca.2010.02.024. Epub 2010 Mar 19. Eur J Cancer. 2010. PMID: 20303742 Review.

6

c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 null mice.

Olaku V, Matzke A, Mitchell C, Hasenauer S, Sakkaravarthi A, Pace G, Ponta H, Orian-Rousseau V. Olaku V, et al. Mol Biol Cell. 2011 Aug 1;22(15):2777-86. doi: 10.1091/mbc.E11-02-0134. Epub 2011 Jun 16. Mol Biol Cell. 2011. PMID: 21680714 Free PMC article.

7

Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44.

Fuchs K, Hippe A, Schmaus A, Homey B, Sleeman JP, Orian-Rousseau V. Fuchs K, et al. Cell Death Dis. 2013 Oct 3;4(10):e819. doi: 10.1038/cddis.2013.364. Cell Death Dis. 2013. PMID: 24091662 Free PMC article.

8

CD44 is a multidomain signaling platform that integrates extracellular matrix cues with growth factor and cytokine signals.

Orian-Rousseau V, Sleeman J. Orian-Rousseau V, et al. Adv Cancer Res. 2014;123:231-54. doi: 10.1016/B978-0-12-800092-2.00009-5. Adv Cancer Res. 2014. PMID: 25081532 Review.

9

Perspectives of CD44 targeting therapies.

Orian-Rousseau V, Ponta H. Orian-Rousseau V, et al. Arch Toxicol. 2015 Jan;89(1):3-14. doi: 10.1007/s00204-014-1424-2. Epub 2014 Dec 5. Arch Toxicol. 2015. PMID: 25472903 Review.

10

Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling.

Matzke-Ogi A, Jannasch K, Shatirishvili M, Fuchs B, Chiblak S, Morton J, Tawk B, Lindner T, Sansom O, Alves F, Warth A, Schwager C, Mier W, Kleeff J, Ponta H, Abdollahi A, Orian-Rousseau V. Matzke-Ogi A, et al. Gastroenterology. 2016 Feb;150(2):513-25.e10. doi: 10.1053/j.gastro.2015.10.020. Epub 2015 Oct 24. Gastroenterology. 2016. PMID: 26597578 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters